FST and thyroid cancer: Since increased follistatin serum levels were found in thyroid cancer patients and correlated with advanced tumor aggressiveness [43], a strong reduction of follistatin secretion may support a role for macrophages in the reduced invasion and migration of C3948 cancer cells observed.